Loading
Cancer pharmacologist at UC San Diego known for work on G-protein signalling and mTOR-targeted therapy in head and neck cancer.
J. Silvio Gutkind, PhD, is Associate Director for Basic Science at UC San Diego Moores Cancer Center and Chair of the Department of Pharmacology. His laboratory studies G-protein-coupled receptor and PI3K/mTOR signalling in cancer, translating these findings into clinical trials of mTOR inhibitors and immunotherapy combinations in head and neck squamous cell carcinoma.
Shares Oncogene and the tag clinician-scientist.
Shares Head and neck squamous cell carcinoma and the tags clinician-scientist, head and neck cancer.
Shares Head and neck squamous cell carcinoma and the tags clinician-scientist, head and neck cancer.
Shares Head and neck squamous cell carcinoma and the tags clinician-scientist, head and neck cancer.
Shares UC San Diego Moores Cancer Center and the tag clinician-scientist.
Shares Head and neck squamous cell carcinoma and the tags clinician-scientist, head and neck cancer.
Shares Head and neck squamous cell carcinoma and the tags clinician-scientist, head and neck cancer.
Shares Head and neck squamous cell carcinoma and the tags clinician-scientist, head and neck cancer.